单纯糖尿病不损害无并发症白内障手术的恢复
该研究基于两项双盲随机临床试验的事后分析,纳入276眼(糖尿病56眼,非糖尿病220眼)行常规白内障手术,比较第28天结果。糖尿病患者在仅用激素单药治疗时中央视网膜厚度变化小于非糖尿病者,其他指标如房水闪辉、视力、满意度及黄斑囊样水肿发生率均无统计学差异。
要点
- 糖尿病患者无视网膜并发症时,白内障术后第28天恢复与非糖尿病者相当。
- 假性晶状体眼黄斑囊样水肿(PCME)在非糖尿病者中更常见(7/8眼),但P=1.000。
核心结论
- 糖尿病本身不损害无并发症白内障手术的恢复,仅激素单药治疗时中央视网膜厚度变化较小。
研究设计与样本
- 事后治疗分析,数据来自2项双盲随机临床试验,在芬兰Kymenlaakso中央医院进行。
- 共纳入276眼(266例患者),糖尿病组56眼,非糖尿病组220眼,比较术前和第28天结果。
关键数值与推荐
- 第28天假性晶状体眼黄斑囊样水肿:8眼中7眼为非糖尿病者(P=1.000)。
临床怎么用
- 无视网膜并发症的糖尿病患者可预期白内障术后恢复与非糖尿病者相似。
- 术后激素单药治疗时需关注非糖尿病患者的中央视网膜厚度变化。
局限性
- 研究为事后分析,样本量有限,糖尿病组仅56眼。
- 仅评估第28天结果,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To study the outcomes of uneventful cataract surgery in diabetic patients without retinal complications. DESIGN: A post hoc treatment analysis using data from 2 double-masked randomized clinical trials. METHODS: Setting: Conducted at Kymenlaakso Central Hospital, Kotka, Finland. PROCEDURE: A total of 276 eyes of 266 patients undergoing routine cataract surgery were included in the study. Patients with type I or II diabetes (n = 56 eyes) were compared to nondiabetic patients (n = 220 eyes). Clinical evaluation was conducted by the operating physician, and outcome measures taken before surgery and day 28 were recorded by a research technician. RESULTS: Patient age, sex distribution, and all baseline ophthalmic and surgical parameters were comparable for the nondiabetic and diabetic patient groups. Increase in aqueous flare 6.3 ± 16.4 photon units (pu)/ms vs 3.7 ± 8.9 pu/ms (mean ± standard deviation; P = .282), central retinal thickness (CRT) 12.0 ± 38.2 μm vs 5.9 ± 15.8 μm (P = .256), corrected distance visual acuity 0.57 ± 0.31 decimals vs 0.53 ± 0.35 decimals (P = .259), and patient satisfaction 9.3 ± 0.9 vs 9.2 ± 1.1 (P = .644) were comparable for nondiabetic and diabetic patients. In eyes with steroid monotherapy (n = 64), CRT increased 38.1 ± 72.8 μm in nondiabetic patients compared to 7.8 ± 6.6 μm in diabetic ones (P = .010). In eyes with nonsteroidal anti-inflammatory drug (NSAID) monotherapy (n = 157), CRT increased 5.7 ± 18.4 μm in nondiabetic patients compared to 6.2 ± 20.5 μm in diabetic ones (P = .897). Among eyes with steroid and NSAID combination therapy (n = 55), CRT increased 3.6 ± 4.1 μm in nondiabetic patients compared to 2.9 ± 3.2 μm in diabetic ones (P = .606). At 28 days postsurgery, pseudophakic cystoid macular edema (PCME) was reported in 8 eyes, of which 7 were in nondiabetic patients (P = 1.000). CONCLUSIONS: Diabetic patients showed less change in CRT when compared to controls in steroid monotherapy. Other outcome measurements shows no statistical differences.
引用
- Danni R, Taipale C, Ilveskoski L, et al. Diabetes Alone Does Not Impair Recovery From Uneventful Cataract Surgery. Am J Ophthalmol. 2018. PMID: 30308203. doi:10.1016/j.ajo.2018.09.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。